Strong performance in US market to support Indian pharma’s growth in FY2024: ICRA EP News Bureau Jan 4, 2024 Revenues of ICRA’s sample set of companies to expand by 9-11 per cent in FY2024, OPM to improve by 150-200 bps to 22-23 per cent…